Admin Control Panel

New Post | Settings | Change Layout | Edit HTML | Edit posts | Sign Out


March20 podcast Dr Hazen
anti-TMA pill in a year or 2 ? (scroll 12 mins)

Additional info:
MEBO Karen
at UK Findacure conf 2020

Scroll down and select country

MEBO Map Testing & Meetups

Full details :
want listed ? contact

MEBO - UBIOME study 2018



MEBO Gut Microbiome Study
"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"
Funded by uBiome Research Grant

"Microbial Basis of Systemic Malodor and PATM Conditions (PATM)"

Dynamics of the Gut Microbiota in
Idiopathic Malodor Production

Started May 2018 - Ongoing

Current people sent kits : 100/100
3 kits per person


Participation info : LINK English

MEBO Private Facebook Group
to join : go to
or contact
Join/Watch the weekly
BO Sufferers Podcasts



TMAU Petition world
TMAU UK end total:262
TMAU UK ends 23/01/20
TMAU Petition USA end total 204
USA : Moveon open
TMAU (Dominican)
Metabolomic Profiling Study

Start : Aug 2016
Stage 1 : 27 Canadian volunteers to test
Latest click here (26 oct) :
17 samples returned

Note : Stage 1 is Canada only.
Return cut-off date : passed
Analysis can take 6/8 weeks
Analysis start in/before Nov
MEBO Research is a
NORD Member Organization
See RareConnect TMAU

Popular Posts (last 30 days)

Upcoming get-togethers

Let us know if you want a meetup listed
Follow MeBOResearch on Twitter

Blog Archive

Denver TMAU Test Lab survey click here
click to Read more/less

USA survey for anyone who wants to improve Denver TMAU test

begun : Dec22
end : no ending for now

A trainee genetic counselor is working at the Denver TMAU test lab. Probably as part of her training. As a project she wishes feedback on any aspect of the Denver TMAU test and process. You can fill in the survey and/or email her (email address is in survey). It's meant for USA people, but perhaps others can give their view too (as we have so few opportunities).

quote from her rareconnect post

"Hello all! I wanted to make you aware of a research study being conducted to better understand the experience and needs of individuals with trimethylaminuria with a goal of being able to create improved patient and healthcare provider education materials. Any participation is completely voluntary and all responses remain confidential. Feel free to use the contact information within the link with any questions or share the survey with others with TMAU."

see this post for more details

Friday, March 24, 2023

Lactobacillus and Bifidobacterium

The effects of the most widely used probiotics, Lactobacillus and Bifidobacterium, on body odor are not universal and may vary depending on the individual. According to MEBO interviews conducted in 2009 with laboratories offering microbial testing, it was suggested that high levels of Lactobacillus (responsible for the odor of uncooked food waste) may not always be beneficial. Instead, they recommended incorporating probiotics such as Bifidobacteria or Saccharomyces boulardii, along with prebiotic fiber, into the diet to potentially help the MEBO population. D-lactate was one of the tests they offered to quantify overgrowth of bacteria in the small intestine. Nevertheless, D-lactate was elevated in less than 20% in less than 20% of MEBO and PATM groups, as per our early clinical trials.

Data from our microbiome study indicate that while there was a general trend of increasing levels of Bifidobacterium and Lactobacillus in individuals who achieve remission, less than 10% of participants needed to boost levels for both species in order to improve their condition. 

In line with previous knowledge, in MEBO/PATM population, Bifidobacterium (one of the first microbes to colonize the human gastrointestinal tract) was more common in younger individuals. About one third of the participants experienced lesser symptoms when increasing levels of their gut Bifidobacteria, another third benefited from more Lactobacillus and the remaining third felt better when increasing levels of Faecalibacterium prausnitzii (a butyrate-producing anaerobe typically associated with good health). 

Our findings suggest that individuals with the highest bacterial diversity don't benefit from increasing levels of Lactobacillus and Bifidobacterium, while those with low diversity levels do need more probiotic microbes in their system. 

The figure (probiotic data overlayed with the Figure from our published results on diversity and skin bacteria in the gut) demonstrates the complexity of these bacterial perturbations and emphasizes the need to consider more than the most known probiotic species when predicting which treatment will work best for reducing MEBO and PATM symptoms. 

Research has shown that the gut microbiome is far more complex than previously thought, with hundreds of bacterial species interacting in a delicate balance.  Therefore, focusing solely on Lactobacillus and Bifidobacterium may not be enough to promote a healthy gut microbiome for everyone. Besides, different strains of bacteria within the same species can have different effects on the body, and the effects of any given strain can depend on a variety of factors, including the individual's overall health, genetics, other strains in the microbiome, and diet. 

More in the latest Olfactics blog post

get New Posts by EMAIL : Enter your email address :

A EURORDIS and NORD Member Organization


Post a Comment